ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Iowa » Rheumatology

Top Rheumatology Prescribers in Iowa

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MICHAEL BROOKS MD

Rheumatology

8,103

$870K

557
435 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

22%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 21%

$107
Average prescription price

Avg: $109

LAWRENCE RETTENMAIER MD

Rheumatology

6,493

$829K

499
362 are 65+

17%
patients receiving schedule two controlled substances

Avg: 2%

44%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 21%

$128
Average prescription price

Avg: $109

DAVID GERBRACHT M.D.

Rheumatology

6,349

$689K

534
454 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

2%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 21%

$109
Average prescription price

Avg: $109

MARK BURDT DO

Rheumatology

5,454

$639K

395
272 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

19%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 21%

$117
Average prescription price

Avg: $109

JOSEPH GILG MD

Rheumatology

5,358

$467K

458
362 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

19%
patients receiving schedule three controlled substances

Avg: 12%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 21%

$87
Average prescription price

Avg: $109

CLARO PALMA MD

Rheumatology

5,130

$590K

472
335 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 21%

$115
Average prescription price

Avg: $109

MARK NIEMER M.D.

Rheumatology

5,043

$332K

474
403 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

14%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 21%

$66
Average prescription price

Avg: $109

ALAN BRAUN MD

Rheumatology

4,754

$631K

386
273 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

14%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 21%

$133
Average prescription price

Avg: $109

MARY RADIA DO

Rheumatology

4,605

$549K

316
227 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 21%

$119
Average prescription price

Avg: $109

SHAHIN BAGHERI MD

Rheumatology

3,687

$196K

365
318 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 21%

$53
Average prescription price

Avg: $109

DEBENDRA PATTANAIK MD

Rheumatology

3,380

$557K

333
146 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

27%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 21%

$165
Average prescription price

Avg: $109

MICHAEL FINAN MD

Rheumatology

3,093

$216K

287
233 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 21%

$70
Average prescription price

Avg: $109

CORY PITTMAN MD

Rheumatology

3,017

$243K

253
189 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

19%
patients receiving schedule three controlled substances

Avg: 12%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 21%

$80
Average prescription price

Avg: $109

SUSAN JACOBI MD

Rheumatology

2,981

$280K

293
230 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

19%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 21%

$94
Average prescription price

Avg: $109

DAVID STAUB M.D.

Rheumatology

2,854

$381K

268
210 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 12%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 21%

$133
Average prescription price

Avg: $109

CHRISTOPHER RONKAR MD

Rheumatology

2,658

$246K

263
208 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

17%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 21%

$92
Average prescription price

Avg: $109

STEVEN EYANSON MD

Rheumatology

2,353

$358K

298
258 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 21%

$152
Average prescription price

Avg: $109

REBECCA TUETKEN MD PHD

Rheumatology

2,234

$259K

244
145 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 21%

$116
Average prescription price

Avg: $109

ANWER RASHEED M.D.

Rheumatology

1,950

$156K

194
145 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 21%

$80
Average prescription price

Avg: $109

ERIK SWENSON MD

Rheumatology

1,879

$185K

214
171 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

16%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 21%

$98
Average prescription price

Avg: $109

SUNITA PENMATCHA M.D.

Rheumatology

1,448

$185K

166
122 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 21%

$128
Average prescription price

Avg: $109

PETAR LENERT MD

Rheumatology

1,358

$127K

163
103 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 21%

$94
Average prescription price

Avg: $109

STEVEN CRAIG M.D.

Rheumatology

1,258

$181K

183
156 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 21%

$144
Average prescription price

Avg: $109

SCOTT VOGELGESANG MD

Rheumatology

1,162

$154K

98
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

21%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 21%

$133
Average prescription price

Avg: $109

NATHAN JOSEPHSON MD

Rheumatology

1,096

$156K

87
67 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

14%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 21%

$142
Average prescription price

Avg: $109

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank